Centene Corporation in the news
Local integrated healthcare plans
Tamtam found 20 recent articles about Centene Corporation.
- Centene (CNC) Could Be 4% Undervalued As Recovery Narrative Holds
Centene Corporation is considered 4% undervalued by analysts, driven by Medicaid margin recovery, a strong Marketplace business rebound, and recent robust share price performance, though it faces risks related to policy changes.
- Centene Drops 5.5% Amid Sector-Wide Selling
Centene Corporation's stock fell 5.5% as part of a broad selloff in health insurance stocks driven by sector-wide concerns.
- Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina
The HMO industry is supported by diversified health plans and an aging population driving Medicare demand, but faces headwinds from Medicaid regulatory changes and increased醫療utilization, while leveraging technology and strategic acquisitions for growth.
- Centene Corp. stock underperforms Wednesday when compared to competitors
Centene Corp. stock underperformed on Wednesday with a 7.03% drop, marking its second consecutive day of losses.
- Health Net Providing Special Assistance to Members and Providers Affected by MP18 Fire in Humboldt
Health Net is offering emergency support for prescription refills, telehealth, mental health services, and social assistance to members and providers affected by the MP18 fire in Humboldt.
- Is Centene's Health Net (NYSE:CNC) Backing Stockton Housing?
Centene's Health Net is funding affordable housing in Stockton, California, mirroring a St. Louis initiative, while other subsidiaries launch new health plans and community programs.
- Centene: Margin Repair Is Real, But The Shares Already Price It In (NYSE:CNC)
Centene Corporation is a "Hold" due to limited upside from its fair value, despite improved earnings, and faces challenges from potential Medicaid membership losses and future Medicare quality bonus reductions.
- CMS Extends Medicaid Work Requirement Hold-Harmless Period, Boos
CMS extended the Medicaid work requirement hold-harmless period to mid-2027, stabilizing membership for managed care organizations like Centene Corporation, which is currently fairly valued.
- A Look at Centene Corp (CNC) After 4.9% Gain -- GF Value $74.61 vs Price $74.77
Centene Corp's stock rose 4.9% to $74.77, is considered slightly overvalued, and shows strong market performance but has insider selling activity.
- Centene Rallies as Defensive Rotation Adds to Recent Earnings Momentum
Centene Corporation's stock increased by 6.5% following positive earnings momentum, an improved 2026 outlook, debt reduction, and strategic initiatives to enhance care access and administrative efficiency.
- Why Centene Doubters Were Wrong Before A 96% Gain
Centene Corporation achieved a 95.9% shareholder return over the last year, with its Q3 2026 report showing improved net margin despite a continued slight loss, as investor sentiment weighed bullish growth against cautious policy and cost risks.
- BrightSpring, Centene stand out as healthcare's most persistent Strong Buys (XLV:NYSEARCA)
Seven healthcare stocks, including BrightSpring and Centene Corporation, are recognized as Strong Buys by Seeking Alpha Quant Ratings across several subsectors.
- Centene sues the CMS over 2027 Medicare Advantage star ratings
Centene is suing the CMS, alleging the use of illegal measures in calculating its 2027 Medicare Advantage star ratings, which could lead to significant financial losses for the insurer.
- Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma
Centene Corporation is expanding its CHOICE Arrangements benefit program to employees in Ohio and Oklahoma for 2027, building on its successful 2026 launch in Indiana to offer more flexible health coverage options.
- Centene vs. Molina: Which Managed Care Stock Has More Upside?
The document compares Centene and Molina stocks to determine which has more upside, but access is currently interrupted.
- Centene Corp. stock outperforms competitors on strong trading day
Centene Corp.'s stock increased by 2.54% to $67.02 on a mixed trading day, marking its second consecutive day of gains.
- How Evidence Can Guide Prevention Investments
Centene Corporation advocates for using an evidence-based framework, the Evidence-Based Prevention Continuum, to guide investments in preventive healthcare interventions for improved outcomes and resource stewardship.
- Centene Q3 2026 Preview: The Quarter Is Easy, The 2027 Bridge Is Not (NYSE:CNC)
Centene Corporation shares have risen significantly, with an expected Q3 EPS beat, but 2027 earnings normalization and Medicaid performance remain key challenges.
- ACA plan provider takes the top spot on the managed care list
Centene Venture Co. of Florida leads in ACA plan enrollment in Florida, while other providers saw declines, and local universities show notable statistics in selectivity, employment, and endowments.
- Centene's Operations Improve: Does the 12.34X P/E Make it a Buy?
Centene's operating recovery has boosted its stock price and earnings outlook, but sustaining margin gains and overcoming non-recurring benefits are key challenges for future growth.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Centene Corporation?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies